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 Endometriosis is a multifaceted disease that is associated with dysmenorrhea, noncyclic 
pelvic pain, dyspareunia, and infertility 1. It affects approximately 1 in 10 women, up to 200 
million worldwide, and can disrupt every aspect of a woman’s life, including sexual 
relationships, appetite, sleep, exercise, work productivity, and emotional well-being 2. When 
extrapolated, endometriosis is a disease that has a high cost to both patients and society as a 
whole, as patients incur personal charges related to pain control and infertility management, 
while absenteeism and loss of productivity contribute to lost earnings worldwide 3. Despite the 
disease’s prevalence and devastating effects on a woman’s life, the average time from symptom 
presentation to endometriosis diagnosis is 8-12 years, a conservative estimate when considering 
most women with the disease will never be diagnosed 3. This delay in diagnosis and treatment 
has been shown to cause an increase in long term disease sequelae, significant degradation in the 
patient-provider relationship, and further progression of the disease 2,4. 
The cause of this unfortunate delay in diagnosis is multifaceted. A large narrative review 
evaluating the social and psychological impact of endometriosis on women’s lives found that the 
average time between a woman’s initial symptoms and initial presentation for evaluation was 3.7 
years. Many causative social factors were cited, including difficulty perceiving the difference 
between normal and pathologic symptoms, viewing menstruation as shameful or needing to be 
hidden, and reinforcement of symptom concealment from male and female peers 4. The average 
delay from initial clinical presentation to diagnosis was between 3.7 and 5.7 years. Factors 
contributing to medical delay of diagnosis included referral delay, misdiagnosis, and lack of 
provider knowledge, all of which contributed to women feeling ignored or dismissed by 
providers4. A significant number of women reported feeling relieved, legitimized, and often 
angry at the delay after receiving an endometriosis diagnosis, all of which have been shown to 
contribute to a degradation in the patient-provider relationship. After diagnosis, women report 
negative impacts to many aspects of their lives, including intimate relationships, work and 
productivity, social lives, family planning, fertility, sleep quality, and mental health 4. 
At this time, laparoscopy with histologic sampling is the only tool available for definitive 
diagnosis. Due to its cost and inherent risks, this tool is out of reach for many patients, especially 
those that do not have access to a tertiary gynecologic referral center. A less invasive diagnostic 
tool could shorten time to diagnosis, help preserve patient-provider relationship, and potentially 
allow the diagnosis to be made in the primary care setting 3. Transvaginal ultrasound is a low-
cost, highly available tool that has shown significant utility in diagnosing many causes of pelvic 
pain 5. This narrative review will seek to evaluate the current research on the diagnostic 
capability of transvaginal ultrasound (TVUS) for diagnosing endometriotic lesions at ovarian, 
superficial peritoneal, and deeply infiltrating sites. If accuracy is high enough, TVUS as a less 
invasive, less expensive tool for diagnosis could allow providers to evaluate patients for 
endometriosis earlier in their disease, increase quality of patient care, and decrease associated 
costs incurred by both the patient and the health care system. 
 This narrative review will begin with an overview of the natural history of endometriosis, 
including epidemiology, pathophysiology, clinical manifestations, current available treatments, 
and diagnostics. This will be followed by an evaluation and discussion of the current research on 
the diagnostic accuracy of TVUS in the diagnosis of endometriosis. The primary outcome will be 
to analyze whether TVUS can accurately diagnose ovarian, superficial peritoneal, and deeply 
infiltrating endometriosis when compared to laparoscopy with histologic examination. 
Background 
Epidemiology 
 Many patients with endometriosis will experience either no symptoms or mild symptoms 
that may be considered within the normal realm of menstrual-related symptoms. This makes 
identifying the prevalence of endometriosis quite difficult 3. Various studies that have sought to 
determine the general population prevalence have produced highly variable results ranging from 
1% to 15%, with approximately 10% being the accepted value 2. For women with symptomatic 
presentation, prevalence has been reported up to 70% when the presentation includes pelvic pain 
and 50% when the presentation includes infertility 6. There appears to be a genetic association, as 
women with first degree female relatives affected by the disease have a higher likelihood of 
being diagnosed with endometriosis 7. Factors that increase a woman’s risk for endometriosis 
include being nulliparous, early menarche, menstrual cycles shorter than 27 days, menorrhagia, 
height over 68 inches, and low BMI 8. Conversely, protective factors include cycles longer than 
27 days, late menarche, multiparity, and extended periods of lactation. White or caucasian race 




By definition, endometriosis is the presence of endometrial tissue outside of the uterus. 
The pathogenesis of the disease likely includes genetic factors, autoimmune dysregulation, and 
abnormal endocrine signaling, in addition to the presence of ectopic endometrial tissue 9.  The 
ectopic endometrial tissue implants, grows, and causes an inflammatory reaction which can lead 
to scarring and anatomic dysmorphism 8. The exact cause of these ectopic implants is poorly 
understood. A 2014 meta-analysis of 8 papers analyzed genetic data from a total of 11506 
endometriosis cases showed that six genetic loci were significantly associated with 
endometriosis 7. However, analyses have failed to identify a genetic marker consistently 
associated with the disease. 
The leading theory for the pathogenesis of ectopic endometrial tissue implantation is 
retrograde menstruation, in which endometrial tissue flows backward through the fallopian tubes 
and into the abdomen during menstruation 8. However, there is uncertainty surrounding this 
theory, as up to 90% of women have been shown to have retrograde menstruation and 
endometriosis has been diagnosed in prepubescent girls 7.  
After implantation, the endometriotic implants cause pain through inflammatory and 
neurologic responses. A variety of inflammatory markers are involved in the inflammatory 
process, with prostaglandins being the primary culprit 9. The implants have also been shown to 
cause surrounding changes to sympathetic and sensory nerve fibers, with some studies showing 
endometriosis patients to have a higher density of nerve endings within and around implants 9. 
This suggests another possible genetic link to endometriosis symptoms, as a predisposition to 
higher inflammatory markers or increased nerve endings could increase pain signaling and 
symptoms 7. 
The pathogenesis for infertility or subfertility caused by endometriosis is thought to 
correlate with the stage of the disease, with a greater burden of disease associated with more 
inflammatory markers and more scar tissue 9. This increase in inflammatory markers can lead to 
ovarian or endometrial hormonal dysfunction, which is thought to cause a subprime environment 
for ovulation, fertilization, and implantation of a zygote. This dysfunction can occur at any stage 
of endometriosis, including early, minimally-invasive disease, although the process remains 
poorly understood 8. As the disease progresses, more deeply infiltrating lesions can lead to 
significant scarring, adhesions, and subsequent pelvic anatomic dysmorphism. This is also 
thought to lead to a hostile and non-ideal environment for fertility 8. 
Clinical Manifestations 
Endometriotic lesions can implant in a variety of locations, both pelvic and non-pelvic. 
Figure 1 demonstrates common locations of pelvic endometriosis, but does not depict 
endometriosis outside of the pelvis 10. These locations most commonly include the ovaries, 
anterior or posterior uterine cul-de-sac, any of the uterine ligaments, the uterus itself, the 
fallopian tubes, and the sigmoidal bowel 9. A majority of patients present with lesions in more 
than one location, with the ovaries being the most common. In rare cases, endometriotic lesions 
have been diagnosed in locations including the breast, thorax, lung, central nervous system, and 
abdominal organs. This can represent diagnostic challenges, as the symptoms associated with 
lesions in rare locations can be 
nonspecific and intermittent 3. 
When a lesion is located within the 
pelvis, it is classified into one of 
three categories: ovarian, 
superficial peritoneal, or deeply 
infiltrating. Ovarian lesions occur 
on the ovaries, superficial 
peritoneal lesions are less than 
5mm into the peritoneum, and 
deeply infiltrating lesions are 5mm 
or more deep into the peritoneum 8.  
The most common 
presenting complaints of women with endometriosis are pelvic pain, infertility, and ovarian mass 
3. The majority of patients present with some complaint of pain, which can include 
dysmenorrhea, noncyclic pelvic pain, dyspareunia [pain with sex], dyschezia [pain with 
defecation], and dysuria. There is generally a direct association between the location of 
endometriotic lesions and the symptoms experienced. However, a patient’s symptom burden is 
not necessarily correlated with disease burden 3. For example, one patient may present with 
severe pain but only have two to three superficial lesions, while another patient may present with 
Figure 1. Pelvic endometriosis, UNC Center for Endometriosis 
mild pain but have 10+ deeply infiltrating and superficial lesions with severe scarring 2. This 
represents another diagnostic challenge, and demonstrates the importance of practitioners 
maintaining a high degree of suspicion in patients presenting with any degree of chronic pelvic 
pain. 
Current Treatment Options 
 There is no cure for endometriosis; rather, the current treatment options rely on symptom 
management. Treatment plans typically involve a two-fold approach utilizing both medical and 
surgical modalities. The first line medical therapy for endometriosis-related pain are non-
steroidal anti-inflammatory drugs (NSAIDs).11 These medications are particularly well-suited to 
combat the prostaglandin mediated pain caused by endometriosis because of their anti-
prostaglandin properties. NSAIDs are also generally very safe and well-tolerated, making them a 
great option for most women 11. Combined oral hormonal contraceptive (COCs) medications are 
another option for the management of endometriosis-related pain, particularly the pain associated 
with menstrual cycles. By regulating the menstrual cycle and making a patient’s periods lighter, 
shorter, and more regular, COCs can decrease the pain associated with menstruation11. COCs are 
also generally safe and well-tolerated by most populations. If NSAIDs and COCs are ineffective 
at managing pain, medications such as GnRH agonists, Danazol, and aromatase inhibitors are 
further options. These medications work in different ways to reduce the effects of estrogen in a 
woman’s body, including suppressing menstruation and associated pain, but they generally have 
more side effects and are less well tolerated than first line treatments11.  
 The medical treatment of endometriosis-related infertility is similar to the approach to 
infertility treatment in patients without endometriosis. The mainstay of medical treatment is 
clomiphene citrate (Clomid), a medication that stimulates follicle growth and ovulation12. The 
addition of gonadotropins and aromatase inhibitors can also be used to enhance follicle 
stimulation. The next step in medical assistance in infertility is the use of assisted reproduction 
technology (ART). This includes In-Vitro Fertilization (IVF) and Intrauterine Insemination (IUI) 
12. Despite these methods, a diagnosis of endometriosis significantly increases a woman’s 
probability of treatment failure compared to women without endometriosis 12. Progression of the 
disease is shown to be directly related to the probability of failure, with greater severity of 
disease conveying greater risk of IVF failure 12.  
 The surgical management of endometriosis related pain and infertility are similar. 
Surgical management for infertility focuses on correcting distorted pelvic anatomy in women 
with moderate to severe disease 12. Unfortunately, this approach has not been validated in RCTs 
and the fertility benefit from surgery is unclear. However, laparoscopic removal or ablation of 
lesions has been shown to significantly reduce pain symptoms in women with mild and moderate 
symptoms 11. While there is a high return to surgery rate (over 50% at the seven year mark), 
multiple RCTs have demonstrated a benefit to removing lesions at the time of laparoscopic 
diagnosis. This is a major strength of laparoscopy, in that it can be both diagnostic and 
therapeutic. Other surgical options for pain management include removal of ovarian 
endometriomas, neurectomy, and hysterectomy with bilateral salpingo-oophorectomy 11. The 
latter is viewed as a last-resort option for women with debilitating symptoms who have failed 
other therapies and do not desire child-bearing. Even after hysterectomy, disease recurrence is 
still possible and many patients do not achieve complete pain relief. 13  
Diagnosis 
 For definitive diagnosis of endometriosis, surgical biopsy with histologic review remains 
the gold standard 14. This has been the case since the early 20th century. The current standard 
surgical technique is laparoscopy 14. One benefit from this technique is that it can be both a 
diagnostic and therapeutic procedure. This can be helpful if a patient desires surgical 
management for their disease. However, despite years of research, there is no noninvasive 
diagnostic test available 2. Some experienced providers may be comfortable managing the 
disease symptomatically without a surgical diagnosis, but many primary care providers do not 
have sufficient gynecology training to feel comfortable with this 2. This is a significant reason 
why most women will go years without a definitive diagnosis for their endometriosis symptoms. 
At least part of this diagnostic and symptomatic burden could be relieved with a noninvasive 
diagnostic test 2. Research is currently being conductive in a variety of outlets, including 
transvaginal ultrasound (TVUS), transrectal ultrasound (TRUS), and serum biomarkers. TVUS 
currently has the most promise and the most research available as a potential diagnostic test for 
the most common endometriosis locations, and will be the focus of this narrative review. 
Methods 
 A thorough online search was conducted through PubMed, Google Scholar, and The 
Cochrane Library of Systematic Reviews. The search terms ‘endometriosis AND ultrasound 
AND deep,’ ‘endometriosis AND ultrasound AND ovarian,’ and ‘endometriosis AND ultrasound 
AND superficial’ were used. To be included in this review, studies needed to be systematic 
reviews, published since January 1st 2009, evaluate human subjects, include no author overlap 
with other studies, and compare TVUS at ovarian, deeply infiltrating, and/or superficial 
peritoneal endometriosis against laparoscopy with biopsy. Reviews including pregnant patients 
were excluded. For superficial peritoneal endometriosis, the criteria were broadened to include 
primary research due to a lack of systematic reviews evaluating superficial endometriosis. From 
this broadened criteria, 51 studies resulted. To prevent overlap of patient data within reviews, 
only the most recent, relevant paper for each lead author was evaluated. A list of excluded 
studies and the reasons for exclusion can be found in Appendix 1. The four final studies selected 
for this paper were chosen based on relevancy to the clinical question of this paper, 
methodologic quality, and assessment by the “A MeaSurement Tool to Assess systematic 
Reviews 2” (AMSTAR 2) criteria and the “Quality Assessment of Diagnostic Accuracy Studies 
2 (QUADAS 2) tool. A table of the AMSTAR 2 and QUADAS 2 evaluations is found in 
Appendix 2 and Appendix 3.  
Results 
Out of the search and evaluation, two systematic reviews and two diagnostic accuracy 
studies were identified as eligible, relevant, and of good methodological quality in the evaluation 
of TVUS diagnostic accuracy of endometriosis at deeply infiltrating (DIE), ovarian, and 
superficial peritoneal sites. Details on each paper’s features, risk of bias, and methodologic 
quality is available in Table 1. Statistical results from each paper were identified and are listed in 
Table 2, along with the endometriosis locations that were evaluated. 
Table 1. Strengths, limitations, and risk of bias for each paper 
Study Study Type and Set-Up Strengths Limitations Risk of Bias 
Guerriero et. al, 2018. 
Transvaginal ultrasound 
vs magnetic resonance 
imaging for diagnosing 
deep infiltrating 
endometriosis: 
systematic review and 
meta-analysis.  
Systematic review with 
statistical meta-analysis of 
data from head-to-head 
clinical trials comparing 
MRI and TVUS in 
diagnosing DIE 
Relatively high number 
of subjects in analysis 
(n=424), studies within 
review all have the same 
head-to-head set up 







Based on AMSTAR 2 
Criteria, unclear risk of 
bias; authors do not 
declare conflicts of 
interest, sources of 
funding, or list of 
excluded studies. Full 
evaluation in Appendix 2. 
Nisenblat et. al, 2016: 
Imaging modalities for 
the non-invasive 
Systematic review using 
Cochrane methods to assess 
the diagnostic accuracy of 
Large review (49 
articles and 4807 




small sample sizes 
within studies, 
Based on AMSTAR 2 
Criteria, unclear risk of 
bias given authors do not 
list complete list of 
diagnosis of 
endometriosis. 
imaging tools in the 
diagnosis of endometriosis 
(extensive details for 




high/unclear risk of 
bias for each study 
excluded studies; 
however, in setting of 
high volume of studies 
evaluated and the authors 
listing reasons for 
exclusion, would 
consider a low risk of 




evaluation in Appendix 2. 










Participants with chronic 
pelvic pain were recruited 
from tertiary gynecologic 
referral centers, then 
underwent TVUS, history, 
and laparoscopy. Primary 
results included correlation 
between test results and 
accuracy of TVUS findings 
in predicting location of 
endometriosis 
Findings are consistent 
with previous studies 
with similar objectives, 
highly detailed 
description TVUS “soft-
markers” involved in 
the study 
Small sample size, 
high potential for 
referral bias, non-
standardized 





unclear if surgeons 
were blind to 
TVUS results 
Based on the QUADAS-
2 tool, there is a low risk 
of bias in patient 
selection, index test, and 
flow and timing. There is 
an unclear risk of bias in 
the reference standard. 
There is low concern 
regarding applicability. 
Full evaluation in 
Appendix 3. 
Chowdary et. al, 2018. 
Multicentre 
retrospective study to 
assess diagnostic 




Retrospective analysis of 
women who received 
TVUS and laparoscopy in 
their work-up for 
endometriosis. Women 
found to have isolated 
superficial endometriosis 
were included in analysis, 
with primary objective to 
determine accuracy of 
TVUS in detecting 
superficial endometriosis. 
Single sonographer for 
TVUS assessment, 
highly detailed 
description of imaging 
protocol 









Based on the QUADAS-
2 tool, there is a low risk 
of bias in patient 
selection, index test, 
reference standard, and 
flow and timing. There is 
low concern regarding 
applicability. Full 
evaluation in Appendix 3. 
Quality Assessment of Diagnostic Accuracy Studies-2 Tool: 15, A MeaSurement Tool to Assess systematic Reviews-2 Criteria: 16 
Deeply Infiltrating Endometriosis 
Guerriero et. al is a systematic review with meta-analysis that examines and compares the 
accuracy of transvaginal ultrasound (TVUS) and MRI in the diagnosis of deeply infiltrating 
endometriosis (DIE) 17. A total of six studies (n=424) were considered eligible, in that all of the 
study's participants received TVUS, MRI, and laparoscopy (the criterion standard) in the 
evaluation for endometriosis. For the purposes of this narrative review, only the TVUS results 
were examined. The authors broke down their evaluation into specific locations for DIE. 
Specifically, they examined the rectosigmoid, rectovaginal septum, and uterosacral ligaments, 
three of the most common locations for DIE. For the rectosigmoid, the pooled sensitivity and 
specificity of TVUS was found to be 0.85 and 0.96 respectively. For the rectovaginal septum, 
pooled sensitivity and specificity of TVUS was found to be 0.59 and 0.97 respectively. For the 
uterosacral ligaments, pooled sensitivity and specificity of TVUS was found to be 0.67 and 0.86 
respectively. The results are detailed further in Table 2, including confidence intervals. For all 
locations, heterogeneity was found to be moderate to high through the Cochran's Q‐statistic and 
the I2 index. Meta-regression was performed on sample size, prevalence, median patient age, 
number of observers (single/multiple), index test description and reference standard description. 
The authors were unable to find an explanation for the heterogeneity. The authors also did not 
provide a total sensitivity or specificity value for all locations of DIE. Overall, the authors 
concluded that TVUS has valuable diagnostic capability and should be a first line technique for 
evaluating DIE. 
Nisenblat et. al conducted a systematic review evaluating and comparing the diagnostic 
capabilities of a variety of noninvasive tests for diagnosing endometriosis 8 with the laparoscopic 
and histologic sampling standard. This included TVUS, TRUS (trans-rectal ultrasound), MRI, 
and biomarkers. For the purposes of this narrative review, only data involving TVUS was 
evaluated. The authors’ criteria for a test to be considered a replacement diagnostic test for 
laparoscopy is sensitivity 94% or above and specificity 79% or above. For a test to be considered 
a study specified “SpPin” rule-in triage test, sensitivity needed to be 50% or above and 
specificity 95% or above. For a test to be considered a study specified “SnNout” rule-out triage 
test, sensitivity needed to be 95% or above and specificity 50% or above. Through a meta-
analysis of 49 studies including 4807 women, the authors found that TVUS met criteria as a 
SpPin triage test for evaluating DIE at the uterosacral ligaments, rectosigmoid, rectovaginal 
septum, vaginal wall, and the Pouch of Douglas. It failed to meet criteria as a replacement 
diagnostic test. The authors note significant heterogeneity between papers for most of the results.  
The results are detailed further in Table 2, including confidence intervals.This was assessed 
through visual examination of forest plots and co-variate testing when more than 10 studies were 
available for a specific diagnostic test. In these cases, the authors were unable to identify the 
cause of heterogeneity. 
Ovarian Endometriosis 
 Nisenblat et. al included 10 studies that specifically evaluated the diagnostic capability of 
noninvasive tests in the evaluation of ovarian endometriosis 8. Data from these 10 studies plus 
information on ovarian endometriosis from the 39 additional studies was compiled in a meta-
analysis for this evaluation. Using the same criteria as described in the deeply infiltrating 
endometriosis subsection of the results section, the authors found that TVUS met criteria as a 
SpPin triage test (Sn 50% or above, Sp 95% or above) for ovarian endometriosis, in that a 
positive test can rule-in the presence of endometriosis at that location. It failed to meet criteria as 
a replacement diagnostic test for ovarian endometriosis. The results are detailed further in Table 
2, including confidence intervals. The authors note significant heterogeneity between papers for 
most of the results. This was assessed through visual examination of forest plots and co-variate 
testing when more than 10 studies were available for a specific diagnostic test. In these cases, the 
authors were unable to identify the cause of heterogeneity. 
Superficial Peritoneal Endometriosis 
 Reid et. al evaluated 189 women in a multicenter prospective diagnostic accuracy study 5. 
Each woman suffered from chronic pelvic pain, underwent TVUS evaluation, and laparoscopic 
confirmation for endometriosis. The study used a specific TVUS technique to look for “soft-
markers” such as ovarian immobility, Pouch of Douglas obliteration, and site-specific 
tenderness, then correlated the results with findings from laparoscopy to assess for diagnostic 
capabilities. For right ovary immobility, sensitivity and specificity for ipsilateral pelvic sidewall 
superficial endometriosis was 7.0% and 94% respectively. For left ovary immobility, sensitivity 
and specificity was 16% and 87% respectively. Confidence intervals were not provided. 
Additionally, site-specific tenderness to the left adnexa in the absence of ovarian immobility, 
Pouch of Douglas obliteration, and DIE was shown to be significantly correlated with left pelvic 
sidewall superficial endometriosis (p=0.024), although the sensitivity and specificity values were 
not provided and only 112 women met the criteria for this analysis.  
 Chowdary et. al conducted a retrospective diagnostic accuracy study to look specifically 
at pre-surgical factors that could be correlated with superficial endometriosis, including 
symptoms and TVUS characteristics 18. Fifty-three women were identified as eligible for 
analysis in that they were receiving surgical evaluation of chronic pelvic pain or endometriosis, 
received TVUS as part of their preoperative work-up, and were not found to have DIE, ovarian 
endometriosis, or adenomyosis. One sonographer performed all the ultrasounds and was called 
“an experienced sonologist who has specialised in endometriosis” by the authors. Seventy-nine 
percent (42/53) of patients were found to have laparoscopic findings that matched TVUS 
findings (95% CI 68–90%, P<0.0001). Uterosacral ligament thickening on TVUS was found to 
have a sensitivity and specificity of 0.62 and 0.73 respectively. Overall sensitivity and specificity 
values for any positive findings on TVUS were not provided. 
Table 2. Sensitivity and specificity results from the included papers. 
Study Locations Assessed Statistical Findings Conclusions 
Guerriero et. al, 2018. 
Transvaginal ultrasound vs 
magnetic resonance 
imaging for diagnosing 
deep infiltrating 
endometriosis: systematic 








- Sensitivity: 0.85 (95% CI, 0.68–0.94) 
- Specificity: 0.96 (95% CI, 0.85–0.99) 
- LR+: 20.4 (95% CI, 4.7–88.5) 
- LR-: 0.16 (95% CI, 0.07–0.38) 
Rectovaginal septum: 
- Sensitivity: 0.59 (95% CI, 0.26–0.86)  
- Specificity: 0.97 (95% CI, 0.94–0.99) 
- LR+: 23.5 (95% CI, 9.1–60.5) 
- LR-: 0.42 (95% CI, 0.18–0.97) 
Uterosacral ligaments: 
- Sensitivity: 0.67 (95% CI, 0.55–0.77)  
- Specificity: 0.86 (95% CI, 0.73–0.93) 
- LR+: 4.8 (95% CI, 2.6–9.0) 
- LR-: 0.38 (95% CI, 0.29–0.50) 
TVUS is useful as a first 
line tool for evaluating 
suspected deeply infiltrating 
endometriosis 
Nisenblat et. al, 2016: 
Imaging modalities for the 





- Sensitivity: 0.79 (95% CI 0.69, 0.89)  
- Specificity 0.94 (95% CI 0.88, 1.00) 
Ovarian 
- Sensitivity: 0.93 (95% CI 0.87, 0.99)  
- Specificity: 0.96 (95% CI 0.92, 0.99) 
TVUS is a useful first line 
tool for evaluating 
suspected endometriosis. A 
positive result at deeply 
infiltrating or ovarian sites 
is specific enough to rule in 
endometriosis. 
Reid et. al, 2019. The 
association between 
ultrasound-based “soft 




Superficial peritoneal Right ovary immobility 
- Sensitivity: 0.07 
- Specificity: 0.94 
- Likelihood ratios and confidence 
intervals not provided 
Left ovary immobility 
- Sensitivity: 0.16 
- Specificity: 0.87 
- Likelihood ratios and confidence 
intervals not provided 
Site-specific tenderness 
- Sensitivity, specificity, and likelihood 
values not provided 
Certain soft-markers with 
TVUS can be a useful 
indicator in distinguishing 
and diagnosing superficial 
endometriosis from other 
locations. 
Chowdary et. al, 2018. 
Multicentre retrospective 
study to assess diagnostic 
accuracy of ultrasound for 
superficial endometriosis-
Are we any closer? 
Superficial peritoneal TVUS accuracy 
- 79% (42/53), 95% CI 68–90% 
Uterosacral ligament thickening 
- Sensitivity: 0.62 
- Specificity: 0.73 
- Unclear significance 
It is possible to detect 
superficial endometriosis 
with considerable accuracy 




 The primary objective of this narrative review is to analyze the diagnostic accuracy of 
TVUS compared to the traditional laparoscopic technique in diagnosing endometriosis at deeply 
infiltrating, ovarian, and superficial peritoneal sites. While the specificity of TVUS is high 
enough to make it a valuable “rule-in” tool for evaluating deeply infiltrating and ovarian 
endometriosis, it lacks the sensitivity necessary to replace laparoscopy as a definitive diagnostic 
tool for these locations. Guerriero et. al concluded that TVUS performed well enough to be 
considered a first-line tool for evaluating a woman for DIE 17. Nisenblat et. al concluded that 
TVUS meets criteria to be a useful tool to “rule-in” DIE and ovarian endometriosis, in that a 
positive TVUS from a well-trained sonographer can reliably diagnose endometriosis in those 
locations and, thus, should be considered a first line tool for evaluating women with suspected 
endometriosis 8. For superficial peritoneal endometriosis, the data indicate that TVUS has 
potential to be a useful tool in assessing a woman with endometriosis, but Reid et. al and 
Chowdary et. al both concluded that more research is needed to be convincing 5,18. 
 While the generally low sensitivity values prohibit TVUS from being used as a 
replacement for laparoscopic diagnosis, the specificity values are impressively high across the 
board. Altogether, the research shows diagnostic utility in a positive TVUS, in that a patient can 
be diagnosed with endometriosis with reasonable certainty if they have a positive TVUS. 
However, a negative TVUS does not have the same utility. If a woman has a negative TVUS, the 
data here suggest further investigation is warranted before a provider can rule out endometriosis 
with reasonable certainty. This finding holds true for ovarian and deeply infiltrating sites. 
Despite only one of the reviews evaluating ovarian sites, the quality and completeness of the 
review is high enough to consider the findings reliable. The data is less convincing for superficial 
peritoneal sites given the lack of systematic reviews and overall limited data, but the foundation 
has been laid for future research at this location. 
 The quality of data available remains a major limitation of this narrative review. There 
are a limited number of studies evaluating the accuracy of TVUS in endometriosis diagnosis at 
deeply infiltrating and ovarian sites, and there are far fewer that analyze superficial peritoneal 
sites. As such, the quality of data available is stronger for deeply infiltrating and ovarian sites 
than superficial peritoneal sites. Of the studies that are available, they are limited by small 
sample sizes and poor methodological quality. This includes the diagnostic accuracy studies 
from Reid et. al and Chowdary et. al 5,18. The challenge of small sample sizes can be partially 
alleviated with systematic reviews that include meta-analysis, although this produces the 
limitation of data heterogeneity, as seen in Nisenblat et. al and Guerriero et. al. Additionally, the 
nature of the research question makes it difficult to include healthy controls, as it would be 
unethical to perform surgery on an otherwise healthy subject.  
 The inclusion of high-quality systematic reviews with extensive statistical analysis is the 
major strength of this narrative review. Nisenblat et. al in particular was impressively done, with 
data from over 4800 participants and methods that resulted in a low risk of bias 8. Guerriero et. al 
included over 400 participants and was shown to have an unclear risk of bias, but included an 
extensive and very strong meta-analysis 17. Strengths of this review are otherwise limited due to 
the reasons stated above. 
 The results of this narrative review reveal many opportunities for future research. In 
regards to ovarian and deeply infiltrating endometriosis, it is reasonable to conclude that TVUS 
is a useful tool in evaluating endometriosis in these locations when used by an experienced 
sonographer. Research evaluating the diagnostic accuracy of TVUS in the hands of a 
sonographer that does not specialize in endometriosis would serve to improve the usefulness of 
the tool in a setting outside of a tertiary gynecologic referral center. One study evaluating the 
learning curve for sonography students found that a two week course in endometriosis markers 
can improve a sonographer’s accuracy to above 90% for most DIE locations 19. This represents 
another opportunity for future research, as the validation of a sonography curriculum for 
endometriosis can greatly increase the standardization and access of endometriosis trained 
sonographers. In regards to superficial peritoneal endometriosis, larger studies evaluating TVUS 
as a tool for diagnosis are greatly needed. Future research opportunities should include larger 
studies specifically evaluating this location, inclusion of this location in systematic reviews and 
meta-analyses, and validation of positive TVUS markers for this location.  
Conclusions 
 Endometriosis is a complicated disease process that results in ectopic implantation of 
endometrial tissue. Most implants can be classified as deeply-infiltrating, ovarian, or superficial 
peritoneal based on their locations within the pelvis. Women who have endometriosis can suffer 
from physical and non-physical sequelae, including dysmenorrhea, dyspareunia, noncyclic pelvic 
pain, dyschezia, dysuria, depression, anxiety, lost income, and mistrust of healthcare 
professionals. The average time to diagnosis is 8-12 years, a delay that is in part due to the 
requirement of laparoscopy for diagnosis.  
This narrative review sought to understand the current research available for evaluating 
TVUS as a diagnostic tool for deeply infiltrating, ovarian, and superficial peritoneal 
endometriosis. The results reveal a high specificity and limited sensitivity for TVUS at DIE and 
ovarian sites. More research is needed to further validate and standardize evaluation at these 
sites, but the data here is strong enough to consider TVUS a useful first-line tool in the 
evaluation of endometriosis at deeply infiltrating and ovarian sites. In fact, these results suggest a 
positive TVUS can reliably establish the diagnosis of endometriosis at ovarian and deeply 
infiltrating sites. However, a negative TVUS cannot rule out the diagnosis of endometriosis, and 
a provider should pursue further testing and maintain a high degree of suspicion for the disease. 
The data available for superficial peritoneal sites is currently too limited to draw conclusions and 
significant more research is needed.  
Overall, this review reveals that TVUS is a useful, noninvasive, low-cost tool in 
evaluating a woman for endometriosis and has the potential to reduce the time to diagnosis and 
treatment, thereby greatly reducing the burden of disease for a woman. Providers should be 
confident and empowered to use TVUS as a first line in evaluating a woman with a clinical 
picture consistent with endometriosis. This tool can be an important component of improving a 
patient-provider relationship, in that this is a relatively easy, low-cost way for a provider to try 
and reach some answers for a patient. However, the consequences of the poor sensitivity values 
should be discussed in detail with patients. Patients and providers should be aware that a 
negative TVUS does not rule out endometriosis, and providers will need to maintain a high 











Appendix 1: Table of excluded studies 
Study [Year] Reason for Exclusion 
Aloisi [2018] 20 Does not evaluate TVUS (only evaluates laparoscopic narrow band imaging) 
Anaf [2009] 21 Does not evaluate TVUS (only evaluates barium enema) 
Audebert [2015] 22 Not related to primary outcome 
Barra [2018] 23 Not related to primary outcome 
Borsellino [1993] 24 Published prior to 2009 
Casasayas-Carles 
[2014] 25 
Not related to primary outcome 
Daraï [2014] 26 Not related to primary outcome 
Deffieux [2004] 27 Published prior to 2009 
Fancellu [2013] 28 Case report and not related to primary outcome 
Fastrez [2017] 29 Does not evaluate TVUS (only evaluates specific type of PET-CT scan) 
Fernandez [2003] 30 Published prior to 2009 
Gabriel [2011] 31 Not related to primary outcome 
Gonçalves [2016] 32 Not related to primary outcome 
Guerriero [2015] 33 More recent study published from the same lead author 
Guerriero [2016] 34 More recent study published from the same lead author 
Hernández [2005] 35 Published prior to 2009 
Hudelist [2011] 36 Results are specific to bowel endometriosis and are not suitable for comparison with diagnosing DIE 
as a whole 
Jaramillo-Cardoso 
[2018] 37 
Not a systematic review and does not evaluate superficial endometriosis (only evaluates abdominal-
wall endometriosis) 
Keckstein [2000] 38 Published prior to 2009 
Khan [2018] 39 Does not evaluate TVUS (only evaluates MRI) 
Kiesel [2019] 3 Not a systematic review and does not evaluate superficial endometriosis 
Kruse [2012] 40 Not a systematic review and does not evaluate superficial endometriosis 
Leone [2016] 41 Only evaluated women during active pregnancy 
Levy [2013] 42 Not related to primary outcome 
Ma [2019] 43 Not related to primary outcome 
Maignien [2017] 44 Not related to primary outcome 
McCausland [1996] 45 Published prior to 2009 
McCausland [1998] 46 Published prior to 2009 
Moawad [2013] 47 Not a systematic review and does not evaluate superficial endometriosis 
Moore [2002] 48 Published prior to 2009 
Muzii [2016] 49 Not related to primary outcome 
Nisenblat [2016] 50 Only evaluated TVUS diagnostic potential when combined with other tests; derivative of included 
systematic review (Nisenblat, 2016) 
Noventa [2015] 51 Included diagnostic data from non-TVUS techniques 
O’Callaghan [2006] 52 Published prior to 2009 
Parazzini [2018] 53 Not related to primary outcome 
Pickhardt [2007] 54 Published prior to 2009 
Piessens [2019] 55 Does not include laparoscopy and histology as reference value 
Ribeiro [2006] 56 Published prior to 2009 
Rimondi [2018] 57 Not related to primary outcome 
Salvat [2001] 58 Published prior to 2009 
Scardapane [2013] 59 Does not evaluate TVUS (MRI-only review) 
Shoji [2016] 60 Case report, not related to primary outcome 
Silveira [2018] 61 Does not evaluate TVUS; animal study 
Streuli [2017] 62 Not related to primary outcome 
Valentini [2014] 63 Does not evaluate TVUS (only evaluates MRI) 
Wozniak [2015] 64 Not related to primary outcome 










Appendix 2: AMSTAR 2 Risk of Bias tool for systematic reviews 
AMSTAR 2 Criteria Nisenblat et. al, 2016 Guerriero et. al, 2018 
1. Did the research questions and 
inclusion criteria for the review include 
the components of PICO? 
Yes Yes 
2. Did the report of the review contain 
an explicit statement that the review 
methods were established prior to the 
conduct of the review and did the report 
justify any significant deviations from 
the protocol? 
Yes Yes 
3. Did the review authors explain their 
selection of the study designs for 
inclusion in the review? 
Yes Yes 
4. Did the review authors use a 
comprehensive literature search 
strategy? 
Yes Yes 
5. Did the review authors perform study 
selection in duplicate? 
Yes Yes 
6. Did the review authors perform data 
extraction in duplicate? 
Yes Yes 
7. Did the review authors provide a list 
of excluded studies and justify the 
exclusions? 
No; they did provide a list of reasons 
why studies were excluded, but not a 
list of the specific studies 
No; they did provide a list of reasons 
why studies were excluded, but not a 
list of the specific studies 
8. Did the review authors describe the 
included studies in adequate detail? 
Yes Yes 
9. Did the review authors use a 
satisfactory technique for assessing the 
risk of bias (RoB) in individual studies 
that were included in the review? 
Yes, QUADAS-2 tool Yes, QUADAS-2 tool 
10. Did the review authors report on the 
sources of funding for the studies 
included in the review? 
Yes, within the QUADAS-2 tool Yes, within the QUADAS-2 tool 
11. If meta-analysis was performed, did 
the review authors use appropriate 
methods for statistical combination of 
results? 
Yes Yes 
12. If meta-analysis was performed, did 
the review authors assess the potential 
impact of RoB in individual studies on 
the results of the meta-analysis or other 
evidence synthesis? 
Yes Yes 
13. Did the review authors account for 
RoB in primary studies when 
interpreting/discussing the results of the 
review? 
Yes Yes 
14. Did the review authors provide a 
satisfactory explanation for, and 
discussion of, any heterogeneity 
observed in the results of the review? 
Yes Yes 
15. If they performed quantitative 
synthesis did the review authors carry 
out an adequate investigation of 
publication bias (small study bias) and 
discuss its likely impact on the results 
of the review? 
Yes Yes 
16. Did the review authors report any 
potential sources of conflict of interest, 
including any funding they received for 
conducting the review? 
Yes No, there is no explicit statement 
regarding sources of funding or 























Appendix 3: QUADAS-2 tool for primary literature 
QUADAS-2 Criteria Chowdary et. al Reid et. al 
Review Question Do ultrasound findings of 
superficial endometriosis 
correlate with laparoscopic 
findings? 
Are ultrasound ‘soft markers’ 
associated with endometriosis 
type and location based on 
laparoscopic findings? 
Index Test Transvaginal ultrasound Transvaginal ultrasound 
Reference Test Laparoscopy with histologic 
sampling 
Laparoscopy with histologic 
sampling 
Patient Selection: Risk of Bias 
1. Was a consecutive or random sample of patients 
enrolled? 
2. Was a case-control design avoided? 
3. Did the study avoid inappropriate exclusions?  
4. Could the selection of patients have introduced 
bias? 
1. Yes, consecutive 
2. Yes, all cases 
3. Yes, only excluded 
incomplete patients 
4. LOW RISK 
1. Yes, consecutive 
2. Yes, all cases 
3. Yes, only excluded 
women who did not 
receive laparoscopy 
4. LOW RISK 
Patient Selection: Applicability 
1. Is there concern that the patients do not match the 
review question? 
1. LOW RISK 1. LOW RISK 
Index Test: Risk of Bias 
1. Were the index test results interpreted without 
knowledge of the results of the reference 
standard? 
2. If a threshold was used, was it pre-specified? 
3. Could the conduct or interpretation of the index 
test have introduced bias? 
1. Yes, performed 
prior 
2. Yes, predefined and 
only one technician 
3. LOW RISK 
1. Yes, performed prior 
2. Yes, positive test was 
pre-defined and given 
to technicians 
3. LOW RISK 
Index Test: Applicability 
1. Is there concern that the index test, its conduct, or 
interpretation differ from the review question? 
1. LOW RISK 1. LOW RISK 
Reference Standard: Risk of Bias 
1. Is the reference standard likely to correctly 
classify the target condition? 
2. Were the reference standard results interpreted 
without knowledge of the results of the index test? 
3. Could the reference standard, its conduct, or its 
interpretation have introduced bias? 
1. Yes, gold standard 
2. Yes, no knowledge 
of index test results 
3. LOW RISK 
1. Yes, gold standard 
2. Unclear, does not state 
if surgeons knew 
TVUS results 
3. UNCLEAR RISK 
Reference Standard: Applicability 
1. Is there concern that the target condition as 
defined by the reference standard does not match 
the review question? 
1. LOW RISK 1. LOW RISK 
Flow and Timing: Risk of Bias 
1. Was there an appropriate interval between index 
test(s) and reference standard? 
2. Did all patients receive a reference standard? 
3. Did patients receive the same reference standard? 
4. Were all patients included in the analysis? 
5. Could the patient flow have introduced bias? 




4. Yes, 30 histories 
incomplete 
5. LOW RISK 
1. Yes, reference test 
after index test 
2. Yes 
3. Yes 
4. Yes, 31 excluded for 
not receiving reference 
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